Importantly, Siglec-E expression (and co-expression with PD-1) on T cell subsets varied across tissues, showing different levels in the TME, spleen, blood, and tumor-draining lymph nodes, highlighting the relevance of considering the tissular context when exploring the function of this receptor.
